The influence of Bone Morphogenic Protein-2 on the consolidation phase in a distraction osteogenesis model.


Autoria(s): Lesaichot V.; Leperlier D.; Viateau V.; Richarme D.; Petite H.; Sailhan F.
Data(s)

2011

Resumo

We asked whether locally applied recombinant-Bone Morphogenic Protein-2 (rh-BMP-2) with an absorbable Type I collagen sponge (ACS) carrier could enhance the consolidation phase in a callotasis model. We performed unilateral transverse osteotomy of the tibia in 21 immature male rabbits. After a latency period of 7 days, a 3-weeks distraction was begun at a rate of 0.5mm/12h. At the end of the distraction period (Day 28) animals were randomly divided into three groups and underwent a second surgical procedure: 6 rabbits in Group I (Control group; the callus was exposed and nothing was added), 6 rabbits in Group II (ACS group; receiving the absorbable collagen sponge soaked with saline) and 9 rabbits in Group III (rh-BMP-2/ACS group; receiving the ACS soaked with 100μg/kg of rh-BMP-2, Inductos(®), Medtronic). Starting at Day 28 we assessed quantitative and qualitative radiographic parameters as well as densitometric parameters every two weeks (Days 28, 42, 56, 70 and 84). Animals were sacrificed after 8 weeks of consolidation (Day 84). Qualitative radiographic evaluation revealed hypertrophic calluses in the Group III animals. The rh-BMP-2/ACS also influenced the development of the cortex of the calluses as shown by the modified radiographic patterns in Group III when compared to Groups I and II. Densitometric analysis revealed the bone mineral content (BMC) was significantly higher in the rh-BMP-2/ACS treated animals (Group III).

Identificador

http://serval.unil.ch/?id=serval:BIB_67D79A124C88

isbn:1879-0267 (Electronic)

doi:10.1016/j.injury.2011.05.039

pmid:21726857

isiid:000296758100011

Idioma(s)

en

Fonte

Injury, vol. 42, no. 12, pp. 1460-1466

Palavras-Chave #Absorbable Implants; Analysis of Variance; Animals; Bone Density/drug effects; Bone Morphogenetic Protein 2/administration & dosage; Bone Morphogenetic Protein 2/pharmacology; Bone Regeneration/drug effects; Bone Regeneration/physiology; Bony Callus/drug effects; Bony Callus/physiology; Collagen Type I; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Osteogenesis, Distraction; Osteotomy; Rabbits; Random Allocation; Recombinant Proteins/administration & dosage; Recombinant Proteins/pharmacology; Tibia/radiography; Tibia/surgery; Time Factors
Tipo

info:eu-repo/semantics/article

article